Fibrinogen is a clotting protein that helps blood form a strong, stable clot after injury. A low fibrinogen blood test means the blood has too little usable fibrinogen, or the fibrinogen present is not working well enough. This matters because fibrinogen is one of the last building blocks in the clotting process: thrombin turns fibrinogen into fibrin, and fibrin forms the mesh that holds a clot together.
Low fibrinogen has several possible causes, including severe bleeding, disseminated intravascular coagulation, advanced liver disease, major trauma, pregnancy-related bleeding, inherited fibrinogen disorders, and certain treatments. The seriousness depends on the level, the trend, symptoms, and the clinical situation. A mildly low result in a stable person needs follow-up. A very low result during active bleeding, childbirth, surgery, trauma, sepsis, or liver failure needs urgent medical attention.
- Low fibrinogen usually means a level below about 200 mg/dL, though reference ranges vary by lab.
- Severe bleeding risk rises sharply when fibrinogen falls below 100 mg/dL, especially with active bleeding or abnormal PT, aPTT, platelets, or D-dimer.
- A typical adult reference range is about 200–400 mg/dL, equal to 2.0–4.0 g/L.
- Pregnancy normally raises fibrinogen, so a “normal-low” result near 200 mg/dL can be concerning during heavy obstetric bleeding.
- The most common acquired causes include DIC, major blood loss, massive transfusion, advanced liver disease, and increased clot breakdown.
- Follow-up often includes PT/INR, aPTT, thrombin time, reptilase time, D-dimer, platelet count, liver tests, and sometimes fibrinogen antigen or genetic testing.
Table of Contents
- What Low Fibrinogen Means
- Normal Range and Severity Levels
- Symptoms and Bleeding Risk
- Common Causes of Low Fibrinogen
- Related Tests and Result Patterns
- When Low Fibrinogen Needs Urgent Care
- Treatment and Follow-Up
- Questions to Ask About Your Result
What Low Fibrinogen Means
Low fibrinogen means the blood has less clot-building material than expected. Fibrinogen is also called factor I. It is made mostly in the liver, released into the bloodstream, and used when the body needs to stop bleeding. When a clot forms, thrombin cuts fibrinogen into fibrin strands. These strands weave through platelets and red blood cells to make a clot firmer and harder to break apart.
A low result is called hypofibrinogenemia when the amount of fibrinogen is reduced. A near-absent level is called afibrinogenemia. A different problem, called dysfibrinogenemia, means the fibrinogen level looks normal or near normal, but the fibrinogen does not work properly. Some people have both low amount and poor function, called hypodysfibrinogenemia.
The most important first question is whether the test measured fibrinogen activity or fibrinogen antigen. Fibrinogen activity measures how well fibrinogen works in clot formation. Fibrinogen antigen measures how much fibrinogen protein is present. Most routine fibrinogen results are activity-based, often using the Clauss fibrinogen method.
This difference explains why two people with similar “fibrinogen” numbers can have different risks. A person with low activity and low antigen has too little fibrinogen. A person with low activity but normal antigen might have fibrinogen that is present but dysfunctional. That second pattern points toward dysfibrinogenemia, certain liver-related fibrinogen changes, or test interference.
A low fibrinogen result does not stand alone. Clinicians interpret it with the rest of the clotting picture, often including a coagulation panel, platelet count, bleeding symptoms, medications, liver status, pregnancy status, and whether the result is falling quickly.
Normal Range and Severity Levels
A common adult fibrinogen reference range is about 200–400 mg/dL, or 2.0–4.0 g/L. Some laboratories use slightly different ranges, such as 180–350 mg/dL or 200–450 mg/dL. Always compare your value with the reference interval printed on your report.
Fibrinogen is also an acute-phase protein, which means the body raises it during inflammation, infection, pregnancy, injury, and some cancers. For that reason, a “normal” value does not always mean fibrinogen is ideal for the situation. During pregnancy, especially late pregnancy, fibrinogen is normally higher than in nonpregnant adults. A level that looks low-normal in another adult can be clinically low during postpartum hemorrhage or placental abruption.
| Fibrinogen level | Common interpretation | Why it matters |
|---|---|---|
| About 200–400 mg/dL | Typical adult reference range | Usually enough fibrinogen for normal clot formation when other clotting factors and platelets are adequate. |
| 150–199 mg/dL | Mildly low in many labs | Often needs repeat testing and context, especially before surgery, during pregnancy, or with bleeding symptoms. |
| 100–149 mg/dL | Moderately low | Bleeding risk rises, especially with trauma, surgery, liver disease, DIC, low platelets, or prolonged PT/aPTT. |
| Below 100 mg/dL | Severely low | Often clinically significant, especially with active bleeding or critical illness. |
| Very low or undetectable | Severe deficiency or heavy consumption | Can occur with inherited afibrinogenemia, severe DIC, massive bleeding, or major liver failure. |
The number also matters differently by setting. In major trauma, many protocols treat fibrinogen as critically low when bleeding is present and fibrinogen is at or below about 150 mg/dL. In obstetric hemorrhage, concern often starts at a higher level, around 200 mg/dL, because pregnancy should raise fibrinogen. In advanced cirrhosis, fibrinogen below 100 mg/dL has been linked with bleeding, but the full bleeding risk also depends on infection, kidney injury, procedure type, platelet count, and overall liver function.
A low result should be compared with prior results. A stable value of 170 mg/dL in a person with a known inherited mild deficiency is different from a sudden fall from 450 to 160 mg/dL during sepsis, trauma, or postpartum bleeding. The direction of change often tells more than one isolated value.
For readers comparing related results, a separate fibrinogen normal range guide helps explain standard reference values, while high results are interpreted differently because fibrinogen also rises with inflammation.
Symptoms and Bleeding Risk
Low fibrinogen increases bleeding risk because clots do not form a strong fibrin mesh. Platelets can still start a plug, but the plug breaks down more easily when fibrinogen is too low or does not function well.
Common symptoms linked with low fibrinogen include:
- Easy bruising or large bruises after minor bumps
- Frequent or prolonged nosebleeds
- Bleeding gums without clear dental cause
- Heavy or prolonged menstrual bleeding
- Bleeding that restarts after seeming to stop
- Prolonged bleeding after dental work, surgery, childbirth, or injury
- Blood in urine or stool
- Large muscle bleeds or joint bleeds in severe inherited deficiency
- Umbilical stump bleeding in newborns with severe congenital deficiency
Bleeding risk is highest when low fibrinogen appears with other clotting problems. A person with low fibrinogen, low platelets, prolonged PT, prolonged aPTT, and high D-dimer has a very different risk profile than someone with mildly low fibrinogen and otherwise normal tests. This is why doctors often look at fibrinogen together with prothrombin time, INR, aPTT, platelet count, and clot breakdown markers.
Low fibrinogen does not always cause bleeding. Some inherited fibrinogen disorders cause few symptoms until surgery, childbirth, dental extraction, or trauma. Dysfibrinogenemia is especially unpredictable because abnormal fibrinogen can cause bleeding, clotting, both, or no symptoms. A personal or family history of unusual bleeding, pregnancy loss, thrombosis, or abnormal clotting tests makes this possibility more important.
The location of bleeding also changes the urgency. Minor bruising needs medical review when unexplained or recurrent. Bleeding inside the brain, abdomen, chest, digestive tract, or after childbirth is an emergency. A very low fibrinogen result during active bleeding needs rapid treatment because the body cannot build stable clots without enough functional fibrinogen.
Common Causes of Low Fibrinogen
Low fibrinogen develops through five main pathways: the body uses it up, loses it through bleeding, dilutes it during resuscitation, breaks it down too fast, or fails to make enough. Inherited fibrinogen disorders are less common but important, especially when low results appear early in life or run in families.
Disseminated intravascular coagulation
Disseminated intravascular coagulation, or DIC, is one of the most important acquired causes. In DIC, widespread clotting activation uses up fibrinogen, platelets, and clotting factors. At the same time, the body breaks down clots, raising D-dimer and fibrin degradation products.
DIC is not a single disease. It is a severe reaction to another problem, such as sepsis, major trauma, obstetric complications, advanced cancer, severe pancreatitis, major transfusion reactions, or shock. The classic lab pattern includes low or falling fibrinogen, low platelets, prolonged PT and aPTT, and high D-dimer. Early DIC can show normal or even high fibrinogen because inflammation raises fibrinogen, so a downward trend is often more revealing than one value.
Major bleeding, trauma, and massive transfusion
Fibrinogen is one of the first clotting factors to fall during major hemorrhage. Severe trauma, major surgery, gastrointestinal bleeding, ruptured aneurysm, and postpartum hemorrhage can lower fibrinogen quickly. Large volumes of IV fluids and red blood cell transfusion without enough clotting factor replacement dilute fibrinogen further.
In these settings, a low fibrinogen result is not just a lab abnormality. It can signal that the person is developing a serious bleeding-related coagulopathy. Trauma teams and operating room teams often use fibrinogen activity, viscoelastic testing such as TEG or ROTEM, and clinical bleeding to decide whether fibrinogen replacement is needed.
Advanced liver disease
The liver makes fibrinogen, so severe liver dysfunction can lower production. Advanced cirrhosis, acute liver failure, severe alcoholic hepatitis, massive liver injury, and end-stage liver disease can all affect fibrinogen. Liver disease can also produce abnormal fibrinogen that does not clot normally.
Bleeding risk in liver disease is complex. INR can be high, platelets can be low, fibrinogen can be low, and yet the body also has reduced natural anticoagulants. This creates a fragile balance rather than a simple “thin blood” state. Clinicians often interpret low fibrinogen in liver disease alongside infection, kidney function, platelet count, planned procedure type, active bleeding, and liver function tests.
Pregnancy and obstetric bleeding
Pregnancy normally raises fibrinogen. That rise helps prepare the body for delivery, when bleeding risk is naturally higher. Because of this, a falling fibrinogen level during pregnancy or after delivery can be an early warning sign during serious obstetric bleeding.
Important pregnancy-related causes include placental abruption, postpartum hemorrhage, amniotic fluid embolism, severe preeclampsia or HELLP syndrome, fetal demise with coagulopathy, and DIC. In heavy obstetric bleeding, fibrinogen near or below 200 mg/dL is often treated as concerning because pregnancy values should be higher than nonpregnant values.
Increased fibrinolysis
Fibrinolysis is the body’s clot-breakdown system. It is useful when it removes clots after healing, but excessive fibrinolysis breaks down clots too quickly and can reduce usable fibrinogen.
This can happen in severe liver disease, major trauma, some obstetric emergencies, certain cancers, and after clot-busting drugs such as alteplase. Some surgical settings, especially procedures involving large raw tissue surfaces or organs rich in fibrinolytic activity, also increase clot breakdown. Labs can show low fibrinogen with high D-dimer or fibrin degradation products.
Inherited fibrinogen disorders
Inherited fibrinogen disorders are rare, but they matter when low fibrinogen is persistent, unexplained, present from childhood, or found in relatives. The main types are:
- Afibrinogenemia: little to no fibrinogen
- Hypofibrinogenemia: reduced fibrinogen amount
- Dysfibrinogenemia: abnormal fibrinogen function
- Hypodysfibrinogenemia: both reduced amount and abnormal function
Severe congenital deficiency can cause bleeding in infancy, including umbilical stump bleeding. Milder forms can appear only after surgery, dental work, injury, or childbirth. Some dysfunctional fibrinogen disorders also increase clot risk, so treatment decisions need hematology guidance.
Medication, treatment, and sample-related causes
Some treatments are linked with low fibrinogen or low functional fibrinogen. Examples include thrombolytic drugs, L-asparaginase used in some leukemia treatment, and fibrinogen consumption during extracorporeal circulation or major surgery. Anticoagulants such as heparin do not usually lower fibrinogen itself, but they can interfere with some clot-based tests if the sample is contaminated or the assay is affected.
Specimen problems also matter. A clotted sample, underfilled citrate tube, heparin contamination from a central line, delayed processing, or improper handling can create misleading clotting results. When the result does not fit the clinical picture, repeating the test from a clean peripheral draw is often the first practical step.
Related Tests and Result Patterns
A low fibrinogen result becomes more useful when matched with related tests. These tests help show whether the issue is reduced production, consumption, dilution, fibrinolysis, inherited deficiency, dysfunctional fibrinogen, or sample interference.
| Test | What it helps show | Common pattern with low fibrinogen |
|---|---|---|
| PT/INR | Extrinsic and common clotting pathways | Often prolonged in DIC, liver disease, vitamin K-related factor deficiency, and major coagulopathy. |
| aPTT | Intrinsic and common clotting pathways | Can be prolonged when fibrinogen is very low, in DIC, heparin exposure, factor deficiencies, or inhibitors. |
| Thrombin time | Final conversion of fibrinogen to fibrin | Often prolonged with low fibrinogen, dysfunctional fibrinogen, heparin, or direct thrombin inhibitors. |
| Reptilase time | Fibrinogen-to-fibrin step without heparin effect | Helps separate heparin effect from fibrinogen disorders when thrombin time is prolonged. |
| D-dimer or FDP | Clot formation and breakdown | Often high in DIC, major clot breakdown, trauma, infection, and active thrombosis or bleeding states. |
| Platelet count | Platelet number | Low platelets plus low fibrinogen suggests consumption, DIC, severe liver disease, or massive bleeding. |
| Fibrinogen antigen | Amount of fibrinogen protein | Low activity with normal antigen suggests dysfunctional fibrinogen rather than simple low amount. |
| Liver panel | Liver injury and synthetic function clues | Abnormal bilirubin, albumin, enzymes, and INR can support liver-related causes. |
A few result patterns are especially useful.
Low fibrinogen with high D-dimer and low platelets points toward consumption or DIC. This pattern needs fast clinical evaluation, especially if the person is ill, bleeding, septic, pregnant, recently delivered, or recovering from trauma.
Low fibrinogen with abnormal liver tests and high INR points toward impaired liver synthesis or liver-related dysfibrinogenemia. The bleeding risk depends on the full liver picture, not only the fibrinogen value.
Low fibrinogen with normal platelets and otherwise normal clotting tests suggests mild congenital hypofibrinogenemia, a stable inherited pattern, or a lab issue. Repeat testing and family history help.
Low fibrinogen activity with normal fibrinogen antigen suggests dysfibrinogenemia. Thrombin time, reptilase time, genetic testing, and hematology review can help clarify it.
Very prolonged thrombin time with a less abnormal reptilase time points toward heparin or a direct thrombin inhibitor effect. When both thrombin time and reptilase time are prolonged, fibrinogen deficiency or dysfunctional fibrinogen becomes more likely. A focused thrombin time test guide can help readers understand this part of the workup.
Because low fibrinogen often overlaps with clot breakdown, doctors frequently order a D-dimer blood test or fibrin degradation products test when DIC or fibrinolysis is a concern.
When Low Fibrinogen Needs Urgent Care
Low fibrinogen needs urgent care when it appears with active bleeding, severe illness, pregnancy-related bleeding, trauma, or symptoms of internal bleeding. The number alone matters, but the clinical setting matters more.
Seek emergency care for any of the following:
- Bleeding that will not stop after firm pressure
- Vomiting blood or material that looks like coffee grounds
- Black, tarry, or bloody stools
- Blood in urine with clots or heavy bleeding
- Severe headache, confusion, weakness on one side, fainting, seizure, or vision changes
- Heavy vaginal bleeding during pregnancy or after delivery
- Severe abdominal pain with dizziness, fainting, or shoulder pain
- Rapidly spreading bruising or swelling after injury
- Shortness of breath, chest pain, or collapse after trauma or surgery
- Low fibrinogen reported during sepsis, shock, major trauma, or ICU care
A fibrinogen level below 100 mg/dL deserves prompt medical contact even without obvious bleeding, especially if it is new. Levels around 100–150 mg/dL also need urgent review when the person has bleeding, planned surgery, liver failure, DIC concern, very low platelets, or abnormal PT/aPTT.
Before a planned procedure, low fibrinogen should be discussed with the clinician doing the procedure and, when needed, a hematologist. Dental extraction, colonoscopy with polyp removal, childbirth, spinal anesthesia, biopsy, major surgery, and emergency operations all place different demands on clotting. A person with a known fibrinogen disorder should have a written bleeding plan before high-risk procedures.
Treatment and Follow-Up
Treatment depends on the cause, severity, bleeding status, and whether the person needs surgery or delivery. Low fibrinogen is not treated the same way in every setting.
Confirm the result when the situation is stable
When the person is stable and not bleeding, the first step is often repeat testing. The repeat test helps rule out sample problems and confirms whether the value is truly low. A clean venipuncture, properly filled citrate tube, and correct processing matter for clotting tests.
Doctors also review medications and recent events. Recent thrombolytic treatment, major surgery, transfusion, sepsis, pregnancy complications, liver disease, cancer treatment, or a new anticoagulant can change the interpretation.
Treat the underlying cause
The most important treatment is correcting the condition driving the low fibrinogen. In DIC, that means treating the trigger, such as sepsis, trauma, obstetric emergency, or cancer-related clotting activation. In liver disease, it means managing liver failure, infection, kidney injury, portal hypertension bleeding, or procedural risk. In major hemorrhage, it means stopping the bleeding source and replacing blood components in a balanced way.
Low fibrinogen during active bleeding is often treated while the underlying cause is being controlled. Waiting for every lab to return can be unsafe in massive bleeding, so hospitals use protocols based on clinical bleeding, fibrinogen levels, and rapid clot assessment.
Replace fibrinogen when bleeding risk is high
Fibrinogen replacement is usually considered when fibrinogen is low and the person is actively bleeding, about to undergo a high-risk procedure, or has a severe deficiency with a known bleeding history. Main replacement options include cryoprecipitate and fibrinogen concentrate. Plasma contains fibrinogen too, but it requires much larger volumes and is not usually the most efficient way to replace fibrinogen alone.
Common clinical targets vary by setting:
- In severe bleeding, many teams aim for fibrinogen above 100–150 mg/dL.
- In major trauma with bleeding, replacement is often considered when fibrinogen is at or below about 150 mg/dL or rapid clot testing shows functional fibrinogen deficit.
- In obstetric hemorrhage, replacement is often considered at higher levels, especially below about 200 mg/dL.
- In cirrhosis with active bleeding, some expert groups aim for fibrinogen above about 100–120 mg/dL.
These targets are not do-it-yourself treatment thresholds. They are hospital-level decisions that account for bleeding speed, body size, diagnosis, pregnancy status, thrombosis risk, and available blood products.
Use antifibrinolytic medicines only when appropriate
Antifibrinolytic medicines, such as tranexamic acid, help slow clot breakdown. They are useful in selected bleeding situations, including some trauma, heavy menstrual bleeding, dental bleeding in bleeding disorders, and postpartum hemorrhage protocols. They are not right for every cause of low fibrinogen. People with active clotting, certain urinary tract bleeding patterns, or high thrombosis risk need individualized decisions.
Plan ahead for inherited fibrinogen disorders
People with inherited fibrinogen disorders benefit from a hematology plan. That plan often covers surgery, dental work, childbirth, injury, sports, travel, emergency care, and whether relatives need testing. Genetic testing is useful when the diagnosis is unclear, severe, or important for family planning.
A bleeding plan often lists the diagnosis, baseline fibrinogen activity and antigen, past bleeding events, recommended products, target fibrinogen levels, and emergency contact information. This is especially important for people with severe hypofibrinogenemia, afibrinogenemia, or dysfibrinogenemia.
Monitor for both bleeding and clotting
Low fibrinogen sounds like a bleeding-only issue, but some fibrinogen disorders also raise clot risk. DIC can cause both bleeding and small-vessel clotting. Liver disease can create a mixed bleeding and clotting state. Fibrinogen replacement itself can contribute to thrombosis risk in selected patients.
Watch for symptoms of clotting as well as bleeding, including one-sided leg swelling, sudden chest pain, shortness of breath, coughing blood, sudden neurologic symptoms, or severe unexplained abdominal pain. These symptoms need urgent care.
Questions to Ask About Your Result
A low fibrinogen result is easier to understand when you ask focused questions. Good questions include:
- Was this fibrinogen activity, fibrinogen antigen, or both?
- What was my exact level in mg/dL or g/L?
- Is this result new, stable, or falling?
- Do my PT/INR, aPTT, platelet count, D-dimer, and liver tests suggest DIC, liver disease, fibrinolysis, or another cause?
- Could the sample have been affected by heparin, a clotted tube, underfilling, or line contamination?
- Do I need repeat testing when I am stable?
- Should I avoid aspirin, NSAIDs, contact sports, dental work, or elective procedures until this is clarified?
- Do I need a hematology referral?
- If I need surgery, delivery, or a biopsy, what fibrinogen target will the team use?
- Should my family members be tested for an inherited fibrinogen disorder?
Bring the full lab report, not just the abnormal line. Include medications, supplements, recent procedures, transfusions, infections, bleeding episodes, pregnancies, miscarriages, clot history, liver disease history, and family history of unusual bleeding or clotting.
Low fibrinogen is not one diagnosis. It is a clue. The right interpretation comes from the level, trend, symptoms, related tests, and the medical setting in which the result appears. A mildly low result often leads to repeat testing and investigation. A very low or rapidly falling result during bleeding or serious illness needs immediate medical action.
References
- Fibrinogen blood test: MedlinePlus Medical Encyclopedia 2025 (Official Medical Encyclopedia)
- Fibrinogen 2026 (Review)
- The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition 2023 (Guideline)
- NAC Statement on Fibrinogen Concentrate Use in Acquired Hypofibrinogenemia 2025 (Position Statement)
- Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management 2021 (Review)
- Peri-Procedural Management of Bleeding Risk in Cirrhosis 2024 (Clinical Guidance)
Disclaimer
This article is for education about low fibrinogen blood test results and does not replace care from a qualified clinician. Low fibrinogen can signal serious bleeding, DIC, liver failure, pregnancy complications, or an inherited clotting disorder. Seek urgent medical care for active bleeding, severe symptoms, pregnancy-related bleeding, trauma, or a very low fibrinogen result.
